• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用简单放射学分类方案的左心室导线位置与心脏再同步治疗长期结果之间的关系。

Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy.

作者信息

Wilton Stephen B, Shibata Mariko A, Sondergaard Rachel, Cowan Karen, Semeniuk Lisa, Exner Derek V

机构信息

Libin Cardiovascular Institute of Alberta, University of Calgary, Canada.

出版信息

J Interv Card Electrophysiol. 2008 Dec;23(3):219-27. doi: 10.1007/s10840-008-9287-1. Epub 2008 Aug 8.

DOI:10.1007/s10840-008-9287-1
PMID:18688701
Abstract

BACKGROUND

Benefit from cardiac resynchronization therapy (CRT) is likely influenced by the location of the left ventricular (LV) lead.

PURPOSE

To evaluate the association of LV lead position with outcome after CRT.

METHODS

Two-hundred and fifty patients with LV dysfunction, New York Heart Association (NYHA) class III (68%) or IV (32%) symptoms, and QRS durations > or =120 ms were followed for a median of 30 months post-CRT. LV lead position was categorized as anterior (n = 20, 8%), lateral (n = 128, 51%), or posterior (n = 102; 41%) using postero-anterior and lateral postoperative chest radiographs.

RESULTS

Median age was 69 years and most (68%) had ischemic LV dysfunction. Clinical response, defined by a > or =1 NYHA class reduction, was lower in patients with an anterior (30%) versus lateral (76%) or posterior (73%) lead position (p = 0.001). An anterior versus nonanterior position was independently associated with a two to three-fold higher risk for nonresponse to CRT, cardiovascular death, death from worsening heart failure or cardiac transplantation, and death from any cause. Repositioning of the LV lead from an anterior to a nonanterior position in seven patients who had not clinically responded to CRT after > or =6 months resulted in clinical improvement in all cases.

CONCLUSIONS

An anterior versus nonanterior LV lead position is independently associated with an increased likelihood of nonresponse to CRT and a higher risk of serious outcomes. Repositioning of an anteriorly placed LV lead to a nonanterior position should be considered in CRT nonresponders.

摘要

背景

心脏再同步治疗(CRT)的获益可能受左心室(LV)导线位置的影响。

目的

评估CRT后LV导线位置与治疗结果之间的关联。

方法

对250例左心室功能不全、纽约心脏协会(NYHA)心功能III级(68%)或IV级(32%)症状且QRS时限≥120毫秒的患者进行CRT治疗后随访,随访时间中位数为30个月。使用术后后前位和侧位胸片将LV导线位置分为前位(n = 20,8%)、侧位(n = 128,51%)或后位(n = 102;41%)。

结果

患者中位年龄为69岁,大多数(68%)有缺血性左心室功能不全。以NYHA心功能分级降低≥1级定义的临床反应,前位导线位置的患者(30%)低于侧位(76%)或后位(73%)导线位置的患者(p = 0.001)。前位与非前位位置独立相关,CRT无反应、心血管死亡、因心力衰竭恶化或心脏移植死亡以及任何原因死亡的风险高出两至三倍。在≥6个月后对CRT无临床反应的7例患者中,将LV导线从先前的前位重新放置到非前位位置,所有病例均出现临床改善。

结论

LV导线前位与非前位位置独立相关,CRT无反应的可能性增加,严重后果风险更高。对于CRT无反应者,应考虑将先前置于前位的LV导线重新放置到非前位位置。

相似文献

1
Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy.使用简单放射学分类方案的左心室导线位置与心脏再同步治疗长期结果之间的关系。
J Interv Card Electrophysiol. 2008 Dec;23(3):219-27. doi: 10.1007/s10840-008-9287-1. Epub 2008 Aug 8.
2
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.轻度症状性心力衰竭患者以及无症状左心室功能不全且既往有心力衰竭症状患者心脏再同步化治疗的随机试验。
J Am Coll Cardiol. 2008 Dec 2;52(23):1834-1843. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.
3
Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.缺血性或非缺血性心肌病所致收缩期左心室功能障碍及轻度心力衰竭症状患者的心脏再同步治疗
Am J Cardiol. 2006 Jul 15;98(2):230-5. doi: 10.1016/j.amjcard.2006.01.080. Epub 2006 May 19.
4
Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads.心脏再同步化治疗中采用外科或经皮左心室起搏导线对心室重构逆转和长期生存的影响。
Heart Rhythm. 2015 Mar;12(3):517-523. doi: 10.1016/j.hrthm.2014.11.013. Epub 2014 Nov 13.
5
Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.心脏再同步治疗中植入困难程序的预测因素。
Europace. 2010 Aug;12(8):1141-8. doi: 10.1093/europace/euq146. Epub 2010 Jun 23.
6
Relationship of Electromechanical Dyssynchrony in Patients Submitted to CRT With LV Lead Implantation Guided by Gated Myocardial Perfusion Spect.门控心肌灌注显像引导下左心室电极植入的心脏再同步治疗患者的机电不同步关系
Arq Bras Cardiol. 2018 Oct;111(4):607-615. doi: 10.5935/abc.20180159. Epub 2018 Aug 23.
7
Assessment of the post-implant final left ventricular lead position: a comparative study between radiographic and angiographic modalities.植入后最终左心室导线位置的评估:影像学和血管造影方法的比较研究。
J Interv Card Electrophysiol. 2010 Oct;29(1):17-22. doi: 10.1007/s10840-010-9497-1. Epub 2010 Jun 17.
8
Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.接受心脏再同步治疗的心力衰竭患者中,反应者与无反应者的心肌基因表达情况。
J Am Coll Cardiol. 2008 Jan 15;51(2):129-36. doi: 10.1016/j.jacc.2007.07.087.
9
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.心脏再同步治疗对无症状或轻度症状性左心室功能不全患者疾病进展的预防作用:来自欧洲队列的REVERSE(收缩期左心室功能不全再同步逆转重塑)试验的见解
J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.
10
Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.左心室导线位置与心脏再同步治疗患者的长期预后
JACC Clin Electrophysiol. 2018 Nov;4(11):1410-1420. doi: 10.1016/j.jacep.2018.07.006. Epub 2018 Aug 29.

引用本文的文献

1
Association between left ventricular lead position and intrinsic QRS morphology with regard to clinical outcome in cardiac resynchronization therapy for heart failure.左心室导线位置与心力衰竭心脏再同步治疗中固有 QRS 形态与临床结局的关系。
Ann Noninvasive Electrocardiol. 2023 Jul;28(4):e13065. doi: 10.1111/anec.13065. Epub 2023 May 18.
2
Three-dimensional mapping in cardiac implantable electronic device - a feasible and effective alternative to fluoroscopy.心脏植入式电子设备的三维标测——一种可行且有效的替代透视技术。
J Interv Card Electrophysiol. 2023 Apr;66(3):783-792. doi: 10.1007/s10840-022-01297-8. Epub 2022 Jul 9.
3

本文引用的文献

1
Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.心脏再同步治疗中左心室导线位置对左心室重构的影响。基于二维超声心动图的圆周应变分析。
Eur Heart J. 2007 May;28(10):1211-20. doi: 10.1093/eurheartj/ehm034. Epub 2007 Apr 10.
2
Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study.左心室导线位置对心脏再同步治疗疗效的影响:一项二维应变超声心动图研究
Heart. 2007 Oct;93(10):1197-203. doi: 10.1136/hrt.2006.095612. Epub 2007 Feb 19.
3
Determinants of Response to Cardiac Resynchronization Therapy.
心脏再同步治疗反应的决定因素
J Innov Card Rhythm Manag. 2022 May 15;13(5):4994-5003. doi: 10.19102/icrm.2022.130503. eCollection 2022 May.
4
Left Ventricular Lead Placement Guided by Reduction in QRS Area.通过QRS面积缩小引导的左心室导线置入
J Clin Med. 2021 Dec 17;10(24):5935. doi: 10.3390/jcm10245935.
5
Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response.瘢痕负担是心脏再同步治疗反应的一个独立且递增的预测因子。
Open Heart. 2019 Jul 5;6(2):e001067. doi: 10.1136/openhrt-2019-001067. eCollection 2019.
6
Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.左束支传导阻滞相关性特发性非缺血性心肌病患者心脏再同步治疗后的性别特异性临床结局:一项NEOLITH II子研究
Ann Noninvasive Electrocardiol. 2019 Jul;24(4):e12641. doi: 10.1111/anec.12641. Epub 2019 Mar 27.
7
Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.左束支传导阻滞相关特发性非缺血性心肌病患者心脏再同步治疗后的心肌恢复:一项NEOLITH II子研究
Ann Noninvasive Electrocardiol. 2019 Mar;24(2):e12603. doi: 10.1111/anec.12603. Epub 2018 Sep 28.
8
Optimizing Cardiac Resynchronization Therapy: an Update on New Insights and Advancements.优化心脏再同步治疗:新见解与进展的最新情况
Curr Heart Fail Rep. 2018 Jun;15(3):156-160. doi: 10.1007/s11897-018-0391-y.
9
Device therapies: new indications and future directions.器械治疗:新适应症及未来方向
Curr Cardiol Rev. 2015;11(1):33-41. doi: 10.2174/1573403x1101141106121553.
10
Three-dimensional electroanatomic mapping of the coronary veins during cardiac resynchronization therapy implant: feasibility and possible applications.心脏再同步治疗植入过程中冠状静脉的三维电解剖标测:可行性及可能的应用
J Interv Card Electrophysiol. 2014 Nov;41(2):147-53. doi: 10.1007/s10840-014-9932-9. Epub 2014 Jul 9.
Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization.
心脏再同步治疗中左心室最佳起搏部位的三维标测
Circulation. 2007 Feb 27;115(8):953-61. doi: 10.1161/CIRCULATIONAHA.106.643718. Epub 2007 Feb 12.
4
Long-term hemodynamic benefit of biventricular pacing depending on coronary sinus lead position.
Herzschrittmacherther Elektrophysiol. 2006 Dec;17(4):185-90. doi: 10.1007/s00399-006-0533-x.
5
Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony.延迟强化磁共振成像可预测存在心室内不同步的患者对心脏再同步治疗的反应。
J Am Coll Cardiol. 2006 Nov 21;48(10):1953-60. doi: 10.1016/j.jacc.2006.07.046. Epub 2006 Oct 31.
6
Left ventricular lead proximity to an akinetic segment and impact on outcome of cardiac resynchronization therapy.左心室电极靠近运动不能节段及其对心脏再同步治疗结果的影响。
J Cardiovasc Electrophysiol. 2006 Jun;17(6):623-7. doi: 10.1111/j.1540-8167.2006.00480.x.
7
Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy.心脏再同步治疗中的组织同步成像与最佳左心室起搏部位
Am J Cardiol. 2006 Jun 1;97(11):1615-21. doi: 10.1016/j.amjcard.2005.12.054. Epub 2006 Apr 7.
8
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.后外侧瘢痕组织对心脏再同步治疗后临床及超声心动图改善情况的影响。
Circulation. 2006 Feb 21;113(7):969-76. doi: 10.1161/CIRCULATIONAHA.105.543678. Epub 2006 Feb 13.
9
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.2006年加拿大心血管学会关于心力衰竭的共识会议建议:诊断与管理
Can J Cardiol. 2006 Jan;22(1):23-45. doi: 10.1016/s0828-282x(06)70237-9.
10
Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy.用于评估心脏再同步治疗反应的临床参数与超声心动图参数对比
Am J Cardiol. 2006 Jan 15;97(2):260-3. doi: 10.1016/j.amjcard.2005.08.030. Epub 2005 Nov 28.